GEARING UP FOR WWJ 950'S THAW RADIOTHON: BID IN THE ONLINE AUCTION NOW!  

Atorvastatin

More Positive Test Results For Plymouth Firm's Cholesterol DrugEsperion Therapeutics Inc. Tuesday announced positive results from a Phase 2a study of its drug candidate ETC-1002 when added to statin therapy in patients with high levels of low density lipoprotein cholesterol, the so-called bad cholesterol, in their blood.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen